These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1761362)

  • 1. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B.
    Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Ito Y; Shinagawa T
    Int J Immunopharmacol; 1991; 13(7):969-75. PubMed ID: 1761362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis.
    Kakumu S; Yoshioka K; Wakita T; Ishikawa T
    Int J Immunopharmacol; 1991; 13(2-3):141-6. PubMed ID: 1906436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Inoue M; Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
    J Immunol; 1989 Jun; 142(11):4006-11. PubMed ID: 2469730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
    Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
    J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B.
    Ishikawa T; Kakumu S; Yoshioka K; Kurokawa S; Kusakabe A; Tahara H; Hirofuji H; Kawabe M
    Liver; 1993 Apr; 13(2):95-101. PubMed ID: 8510492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
    Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
    Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
    J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
    Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
    Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection.
    Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T
    Digestion; 1992; 52(1):26-33. PubMed ID: 1426694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
    Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
    Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.
    Löhr HF; Weber W; Schlaak J; Goergen B; Meyer zum Buschenfelde KH; Gerken G
    Hepatology; 1995 Jul; 22(1):61-8. PubMed ID: 7601434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.
    Schlaak JF; Tully G; Löhr HF; Gerken G; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1999 Mar; 115(3):508-14. PubMed ID: 10193426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
    Niigaki M; Fukuda R; Hamamoto S; Ishimura N; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
    Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.
    Vingerhoets J; Michielsen P; Vanham G; Bosmans E; Paulij W; Ramon A; Pelckmans P; Kestens L; Leroux-Roels G
    J Hepatol; 1998 Jan; 28(1):8-16. PubMed ID: 9537868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection.
    Wakita T; Kakumu S; Tsutsumi Y; Yoshioka K; Machida A; Mayumi M
    Digestion; 1990; 47(3):149-55. PubMed ID: 1707382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
    Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
    Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.